| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.453 | 7.466 | 5.399 | 3.695 | 4.641 | 7.090 | 8.010 | 12.993 | 21.906 |
| Total Income - EUR | - | 2.453 | 7.466 | 5.399 | 3.695 | 4.641 | 7.090 | 8.010 | 13.068 | 22.152 |
| Total Expenses - EUR | - | 366 | 1.436 | 1.836 | 1.875 | 1.404 | 1.202 | 1.155 | 1.118 | 1.401 |
| Gross Profit/Loss - EUR | - | 2.087 | 6.030 | 3.563 | 1.820 | 3.237 | 5.888 | 6.855 | 11.950 | 20.751 |
| Net Profit/Loss - EUR | - | 2.014 | 5.806 | 3.401 | 1.709 | 3.098 | 5.701 | 6.626 | 10.077 | 17.929 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medrespir Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 982 | 368 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 2.574 | 6.036 | 4.477 | 2.432 | 3.495 | 9.326 | 7.218 | 11.638 | 20.865 |
| Inventories | - | 0 | 0 | 10 | 10 | 10 | 10 | 0 | 0 | 0 |
| Receivables | - | 1.117 | 2.462 | 127 | 670 | 2.514 | 634 | 2.159 | 2.980 | 543 |
| Cash | - | 1.457 | 3.573 | 4.340 | 1.752 | 971 | 8.683 | 5.060 | 8.659 | 20.323 |
| Shareholders Funds | - | 2.058 | 5.861 | 3.455 | 1.762 | 3.194 | 8.824 | 6.720 | 10.179 | 19.529 |
| Social Capital | - | 45 | 46 | 45 | 44 | 87 | 85 | 85 | 85 | 84 |
| Debts | - | 516 | 175 | 2.003 | 1.038 | 301 | 502 | 498 | 1.460 | 1.337 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medrespir Srl